New trends in infective endocarditis

Enfermedades Infecciosas y Microbiologia Clinica

Volumn 29, Issue SUPPL. 4, 2011, Pages 22-35

  Fariñas, M Carmen ^a   Llinares, Pedro ^b   Almirante, Benito ^c   Barberán, José ^d   De Dios Colmenero, Juan ^e   Garau, Javier ^f   Gudiol, Francisco ^g   Hernández Quero, José ^h   Mensa, José ⁱ   Montejo, Miguel ^j   Pachón, Jerónimo ^k   Rodríguez Baño, Jesús ^l   Sánchez García, Miguel ^m  

^a UNIVERSITY OF CANTABRIA   (Spain)

^b HOSPITAL JUAN CANALEJO   (Spain)

^c HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^d HOSPITAL CENTRAL DE LA DEFENSA GÓMEZ ULLA   (Spain)

^e HOSPITAL REGIONAL UNIVERSITARIO DE MÁLAGA   (Spain)

^f HOSPITAL MÚTUA DE TERRASSA   (Spain)

^g HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^h HOSPITAL UNIVERSITARIO SAN CECILIO   (Spain)

ⁱ HOSPITAL CLÍNIC   (Spain)

^j HOSPITAL DE CRUCES   (Spain)

^k HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

^l HOSPITAL UNIVERSITARIO VIRGEN MACARENA   (Spain)

^m HOSPITAL CLÍNICO SAN CARLOS   (Spain)

more..

Author keywords

Diagnosis; Endocarditis; Epidemiology; Nosocomial endocarditis; Prognostic factors; Prophylaxis; Treatment

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMPICILLIN; BETA LACTAM ANTIBIOTIC; CEFTRIAXONE; CLINDAMYCIN; CLOXACILLIN; DAPTOMYCIN; GENTAMICIN; LINEZOLID;

ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL ENDOCARDITIS; BARTONELLA QUINTANA; BRAIN EMBOLISM; CANDIDA PARAPSILOSIS; COMPUTER ASSISTED TOMOGRAPHY; COXIELLA BURNETII; DIARRHEA; DRUG APPROVAL; DRUG EFFICACY; EARLY DIAGNOSIS; EMBOLISM; ENTEROCOCCUS FAECALIS; FEVER; GROUP A STREPTOCOCCAL INFECTION; HEART; HEART ABSCESS; HEART VALVE PROSTHESIS; HOSPITAL INFECTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; INTRAVENOUS DRUG ABUSE; LABORATORY DIAGNOSIS; LUNG EMBOLISM; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PACEMAKER; POLYMERASE CHAIN REACTION; PROGNOSIS; PROPHYLAXIS; PROPIONIBACTERIUM; PROSTHESIS INFECTION; PROSTHETIC VALVE ENDOCARDITIS; Q FEVER; RHEUMATIC FEVER; SEROLOGY; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION; STREPTOCOCCAL PHARYNGITIS; THROMBOCYTOPENIA; TRANSESOPHAGEAL ECHOCARDIOGRAPHY;

ENDOCARDITIS; HUMANS; INFECTIOUS DISEASE MEDICINE;

EID: 79953327336     PISSN: 0213005X     EISSN: 15781852     Source Type: Journal    
DOI: 10.1016/S0213-005X(11)70033-7     Document Type: Article

References (94)

1. W. Osler The Gulstonian lectures on malignant endocarditis Br Med J 1 1885 77 79 467-70, 522-26
2. T.M. Bashore, C. Cabell, and V Fowler Jr Update on infective endocarditis Curr Probl Cardiol 31 2006 274 352
3. E. Bouza, A. Menasalvas, P. Muñoz, F.J. Vasallo, M. Del Mar Moreno, and M.A. García Fernández Infective endocarditis - a prospective study at the end of the twentieth century: new predisposing conditions, new etiologic agents, and still a high mortality Medicine (Baltimore) 80 2001 298 307 (Pubitemid 32879291)
4. I.M. Tleyjeh, A. Abdel-Latif, H. Rahbi, C.G. Scott, K.R. Bailey, and J.M. Steckelberg A systematic review of population-based studies of infective endocarditis Chest 132 2007 1025 1035
5. E. Mylonakis, and S.B. Calderwood Infective endocarditis in adults N Engl J Med 345 2001 1318 1330
6. P. Moreillon, and Y.A. Que Infective endocarditis Lancet 363 2004 139 149 (Pubitemid 38068333)
7. Hl. Cooper, J.E. Brady, D. Ciccarone, B. Tempalski, K. Gostnell, and S.R. Friedman Nationwide increase in the number of hospitalizations for illicit injection drug use-related infective endocarditis Clin Infect Dis 45 2007 1200 1203 (Pubitemid 47580320)
8. F.G. De Rosa, S. Cicalini, F. Canta, S. Audagnotto, E. Cecchi, and G. Di Perri Infective endocarditis in intravenous drug users from Italy: The increasing importance in HIV-infected patients Infection 35 2007 154 160 (Pubitemid 46932318)
9. E.E. Hill, S. Vanderschueren, J. Verhaegen, P. Herijgers, P. Claus, and M.C. Herregods Risk factors for infective endocarditis and outcome of patients with Staphylococcus aureus bacteremia Mayo Clin Proc 82 2007 1165 1169 (Pubitemid 47502873)
10. R.B. Hsu, and F.Y. Lin Methicillin resistance and risk factors for embolism in Staphylococcus aureus infective endocarditis Infect Control Hosp Epidemiol 28 2007 860 866
11. M.l. Fernández Guerrero, A. Goyenechea, C. Verdejo, R.F. Roblas, and M. De Gorgolas Enterococcal endocarditis on native and prosthetic valves: a review of clinical and prognostic factors with emphasis on hospital-acquired infections as a major determinant of outcome Medicine (Baltimore) 86 2007 363 377 (Pubitemid 351326059)
12. B.D. Prendergast The changing face of infective endocarditis Heart 92 2006 879 885 (Pubitemid 43974043)
13. C.K. Naber, and R. Erbel Infective endocarditis with negative blood cultures Int J Antimicrob Agents 30 Suppl 1 2007 S32 S36
14. P. Brouqui, and D. Raoult Endocarditis due to rare and fastidious bacteria Clin Microbiol Rev 14 2001 177 207 (Pubitemid 32096213)
15. C. Garzoni, V.A. Nobre, and J. Garbino Candida parapsilosis endocarditis: a comparative review of the literature Eur J Clin Microbiol Infect Dis 26 2007 915 926 (Pubitemid 350077212)
16. C. Landais, F. Fenollar, F. Thuny, and D. Raoult From acute Q fever to endocarditis: serological follow-up strategy Clin Infect Dis 44 2007 1337 1340 (Pubitemid 46717295)
17. T. Lalani, A.K. Person, S.S. Hedayati, L. Moore, D.R. Murdoch, and B. Hoen Propionibacterium endocarditis: a case series from the International Collaboration on Endocarditis Merged Database and Prospective Cohort Study Scand J Infect Dis 39 2007 840 848 (Pubitemid 47470772)
18. A.S. Werner, C.G. Cobbs, D. Kaye, and E.W. Hook Studies on the bacteremia of bacterial endocarditis Jama 202 1967 199 203
19. L.M. Baddour, W.R. Wilson, A.S. Bayer, V.G. Fowler Jr, A.F. Bolger, and M.E. Levison Infective endocarditis: diagnosis, antimicrobial therapy, and management of complications: a statement for healthcare professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, and the Councils on Clinical Cardiology, Stroke, and Cardiovascular Surgery and Anesthesia, American Heart Association: endorsed by the Infectious Diseases Society of America Circulation 111 2005 E394 E434
20. N.P. Jenkins, G. Habib, and B.D. Prendergast Aorto-cavitary fistulae in infective endocarditis: understanding a rare complication through collaboration. Eur Heart J 26 2005 213 214 (Pubitemid 40222358)
21. W.N. Campbell, W. Tsai, and L.A. Mispireta Evaluation of the practice of routine culturing of native valves during valve replacement surgery Ann Thorac Surg 69 2000 548 550 (Pubitemid 30125590)
22. P. Houpikian, and D. Raoult Blood culture-negative endocarditis in a reference center: etiologic diagnosis of 348 cases Medicine (Baltimore) 84 2005 162 173 (Pubitemid 40677362)
23. P.P. Bosshard, A. Kronenberg, R. Zbinden, C. Ruef, E.C. Bottger, and M. Altwegg Etiologic diagnosis of infective endocarditis by broad-range polymerase chain reaction: a 3-year experience Clin Infect Dis 37 2003 167 172 (Pubitemid 36930345)
24. V. Gauduchon, L. Chalabreysse, J. Etienne, M. Celard, Y. Benito, and H. Lepidi Molecular diagnosis of infective endocarditis by pcr amplification and direct sequencing of dna from valve tissue J Clin Microbiol 41 2003 763 766 (Pubitemid 36184193)
25. G. Lisby, E. Gutschik, and D.T. Durack Molecular methods for diagnosis of infective endocarditis Infect Dis Clin North Am 16 2002 393 412 X (Pubitemid 34663643)
26. M. Marín, P. Muñoz, M. Sánchez, M. Del Rosal, L. Alcalá, and M. Rodríguez-Creixems Molecular diagnosis of infective endocarditis by real-time broad-range polymerase chain reaction (pcr) and sequencing directly from heart valve tissue Medicine (Baltimore) 86 2007 195 202 (Pubitemid 47067477)
27. R.W. Watkin, L.V. Harper, A.B. Vernallis, S. Lang, P.A. Lambert, and A.M. Ranasinghe Pro-inflammatory cytokines Il6, Tnf-alpha, Il1beta, procalcitonin, lipopolysaccharide binding protein and C-reactive protein in infective endocarditis J Infect 55 2007 220 225 (Pubitemid 47244920)
28. A. Arvay, and M. Lengyel Incidence and risk factors of prosthetic valve endocarditis Eur J Cardiothorac Surg 2 1988 340 346
29. A. Wang, E. Athan, P.A. Pappas, V.G. Fowler Jr, L. Olaison, and C. Pare Contemporary clinical profile and outcome of prosthetic valve endocarditis Jama 297 2007 1354 1361 (Pubitemid 46513236)
30. H. Alonso-Valle, C. Fariñas-Álvarez, J.M. Bernal-Marco, J.D. García-Palomo, F. Gutiérrez-Díez, and R. Martín-Durán The changing face of prosthetic valve endocarditis at a tertiary-care hospital: 1986-2005 Rev Esp Cardiol 63 2010 28 35
31. M.C. Fariñas, A. Pérez-Vázquez, C. Fariñas-Álvarez, J.D. García-Palomo, J.M. Bernal, and J.M. Revuelta Risk factors of prosthetic valve endocarditis: a case-control study Ann Thorac Surg 81 2006 1284 1290
32. H. Alonso-Valle, C. Fariñas-Álvarez, J.D. García-Palomo, J.M. Bernal, R. Martín-Durán, and J.F. Gutiérrez Díez Clinical course and predictors of death in prosthetic valve endocarditis over a 20-year period J Thorac Cardiovasc Surg 139 2010 887 893
33. G. Habib, C. Tribouilloy, F. Thuny, R. Giorgi, A. Brahim, and M. Amazouz Prosthetic valve endocarditis: who needs surgery? A multicentre study of 104 cases Heart 91 2005 954 959 (Pubitemid 40874090)
34. J.A. San Román, J. López, I. Vilacosta, M. Luaces, C. Sarria, and A. Revilla Prognostic stratification of patients with left-sided endocarditis determined at admission Am J Med 120 2007 E1 E7
35. X. Duval, and C. Leport Prophylaxis of infective endocarditis: current tendencies, continuing controversies Lancet Infect Dis 8 2008 225 232 (Pubitemid 351384827)
36. L.M. Baddour Prophylaxis of infective endocarditis: prevention of the perfect storm Int J Antimicrob Agents 30 Suppl1 2007 S37 41 (Pubitemid 47498985)
37. N. Danchin, X. Duval, and C. Leport Prophylaxis of infective endocarditis: French recommendations 2002 Heart 91 2005 715 718 (Pubitemid 40769206)
38. Fk. Gould, T.S. Elliott, J. Foweraker, M. Fulford, J.D. Perry, and G.J. Roberts Guidelines for the prevention of endocarditis: report of the Working Party of the British Society for Antimicrobial Chemotherapy J Antimicrob Chemother 57 2006 1035 1042 (Pubitemid 44644403)
39. W. Wilson, K.A. Taubert, M. Gewitz, P.B. Lockhart, L.M. Baddour, and M. Levison Prevention of infective endocarditis: guidelines from the American Heart Association: a guideline from the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee. Council on Cardiovascular Disease in The Young, and the Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesia, and the Quality of Care and Outcomes Research Interdisciplinary Working Group Circulation 116 2007 1736 1754
40. L.G. Winston, and A.F. Bolger Modern epidemiology, prophylaxis, and diagnosis and therapy for infective endocarditis Curr Cardiol Rep 8 2006 102 108
41. D. Horstkotte, F. Follath, E. Gutschik, M. Lengyel, A. Oto, and A. Pavie Guidelines on prevention, diagnosis and treatment of infective endocarditis executive summary; the Task Force on Infective Endocarditis of the European Society of Cardiology Eur Heart J 25 2004 267 276 (Pubitemid 38235165)
42. T.S. Elliott, J. Foweraker, F.K. Gould, J.D. Perry, and J.A. Sandoe Guidelines for the antibiotic treatment of endocarditis in adults: report of the Working Party of the British Society For Antimicrobial Chemotherapy J Antimicrob Chemother 54 2004 971 981 (Pubitemid 40136728)
43. Paul-Ehrlich-Gesellschaft Für Chemotherapie (Peg; Paul-Ehrlich-Society for Chemotherapy), Deutsche Gesellschaft Für Kardiologie, Herz-Und Kreislaufforschung (Dgk; German Society for Cardiology, Heart, and Circulatory Research). German Guidelines for the Diagnosis and Management of Infective Endocarditis. Int J Antimicrob Agents. 2007;29:643-57.
44. K. Westling, E. Aufwerber, C. Ekdahl, G. Friman, B. Gardlund, and I. Julander Swedish Guidelines for Diagnosis and Treatment of Infective Endocarditis Scand J Infect Dis 39 2007 929 946 (Pubitemid 350161528)
45. B. Knoll, I.M. Tleyjeh, J.M. Steckelberg, W.R. Wilson, and L.M. Baddour Infective Endocarditis due to Penicillin-Resistant Viridans Group Streptococci Clin Infect Dis 44 2007 1585 1592 (Pubitemid 46871505)
46. S. Fujitani, M.C. Rowlinson, and W.l. George Penicillin G-resistant viridans group streptococcal endocarditis and interpretation of the American Heart Association's Guidelines for the treatment of infective endocarditis Clin Infect Dis 46 2008 1064 1066 (Pubitemid 351589873)
47. L. Olaison, and K. Schadewitz Enterococcal endocarditis in Sweden, 1995-1999: can shorter therapy with aminoglycosides be used? Clin Infect Dis 34 2002 159 166 (Pubitemid 34028346)
48. J. Gavald, P.L. Onrubia, M.T. Gómez, X. Gomis, J.L. Ramírez, and O. Len Efficacy of ampicillin combined with ceftriaxone and gentamicin in the treatment of experimental endocarditis due to Enterococcus faecalis with no high-level resistance to aminoglycosides J Antimicrob Chemother 52 2003 514 517 (Pubitemid 37120740)
49. J. Gavald, C. Torres, C. Tenorio, P. López, M. Zaragoza, and J.A. Capdevila Efficacy of ampicillin plus ceftriaxone in treatment of experimental endocarditis due to Enterococcus faecalis strains highly resistant to aminoglycosides Antimicrob Agents Chemother 43 1999 639 646 (Pubitemid 29109532)
50. J. Gavald, O. Len, J.M. Miró, P. Muñoz, M. Montejo, and A. Alarcón Brief communication: treatment of Enterococcus faecalis endocarditis with ampicillin plus ceftriaxone Ann Intern Med 146 2007 574 579 (Pubitemid 351650538)
51. V.H. Chu, C.W. Woods, J.M. Miró, B. Hoen, C.H. Cabell, and P.A. Pappas Emergence of coagulase-negative staphylococci as a cause of native valve endocarditis Clin Infect Dis 46 2008 232 242 (Pubitemid 351269162)
52. J.L. Haro, J.M. Lomas, A. Plata, J. Ruiz, J. Gálvez, and J. De la Torre Left-sided native valve endocarditis by coagulase-negative staphylococci: an emerging disease Enferm Infecc Microbiol Clin 26 2008 263 268 (Pubitemid 351716795)
53. J.M. Miró, I. Anguera, C.H. Cabell, A.Y. Chen, J.A. Stafford, and G.R. Corey Staphylococcus aureus native valve infective endocarditis: report of 566 episodes from the International Collaboration on Endocarditis Merged Database Clin Infect Dis 41 2005 507 514 (Pubitemid 41099645)
54. V.G. Fowler Jr, J.M. Miró, B. Hoen, C.H. Cabell, E. Abrutyn, and E. Rubinstein Staphylococcus aureus endocarditis: a consequence of medical progress Jama 293 2005 3012 3021 (Pubitemid 40965071)
55. B.C. Millar, B.D. Prendergast, and J.E. Moore Community-associated MRSA (CA-MRSA): an emerging pathogen in infective endocarditis J Antimicrob Chemother 61 2008 1 7
56. C. Tsigrelis, M.D. Armstrong, N.E. Vlahakis, J.A. Batsis, and L.M. Baddour Infective endocarditis due to community-associated methicillin-resistant Staphylococcus aureus in injection drug users may be associated with panton-valentine leukocidin-negative strains Scand J Infect Dis 39 2007 299 302 (Pubitemid 46567379)
57. N.Z. Haque, S.L. Davis, C.L. Manierski, D. Vager, S.M. Donabedian, and M.B. Perri Infective endocarditis caused by Usa300 methicillin-resistant Staphylococcus aureus (MRSA) Int J Antimicrob Agents 30 2007 72 77 (Pubitemid 46874896)
58. A. Soriano, F. Marco, J.A. Martínez, E. Pisos, M. Almela, and V.P. Dimova Influence of vancomycin minimum inhibitory concentration on the treatment of methicillin-resistant Staphylococcus aureus bacteremia Clin Infect Dis 46 2008 193 200 (Pubitemid 351269157)
59. S.H. Kim, K.H. Kim, H.B. Kim, N.J. Kim, E.C. Kim, and M.D. Oh Outcome of vancomycin treatment in patients with methicillin-susceptible Staphylococcus aureus bacteremia Antimicrob Agents Chemother 52 2008 192 197
60. B. Almirante Bacteremia and vascular infections due to Gram-positive microorganisms: new therapeutic options Enferm Infecc Microbiol Clin 26 Supl 2 2008 44 52 (Pubitemid 351896027)
61. J.R. Lentino, M. Narita, and V.L. Yu New antimicrobial agents as therapy for resistant Gram-positive cocci Eur J Clin Microbiol Infect Dis 27 2008 3 15 (Pubitemid 350197870)
62. R.C. Moellering Jr Current treatment options for community-acquired methicillinresistant Staphylococcus aureus infection Clin Infect Dis 46 2008 1032 1037 (Pubitemid 351589868)
63. B.P. Howden, P.B. Ward, P.G. Charles, T.M. Korman, A. Fuller, and P. Du Cros Treatment outcomes for serious infections caused by methicillin-resistant Staphylococcus aureus with reduced vancomycin susceptibility Clin Infect Dis 38 2004 521 528 (Pubitemid 38250962)
64. M.P. Oramas-Shirey, L.V. Buchanan, C.L. Dileto-Fang, C.F. Dailey, C.W. Ford, and D.H. Batts Efficacy of linezolid in a staphylococcal endocarditis rabbit model J Antimicrob Chemother 47 2001 349 352 (Pubitemid 32229578)
65. C.F. Dailey, C.L. Dileto-Fang, L.V. Buchanan, M.P. Oramas-Shirey, D.H. Batts, and C.W. Ford Efficacy of linezolid in treatment of experimental endocarditis caused by methicillin-resistant Staphylococcus aureus Antimicrob Agents Chemother 45 2001 2304 2308 (Pubitemid 32664471)
66. C. Jacqueline, E. Batard, L. Pérez, D. Boutoille, A. Hamel, and J. Caillon In vivo efficacy of continuous infusion versus intermittent dosing of linezolid compared to vancomycin in a methicillin-resistant Staphylococcus aureus rabbit endocarditis model Antimicrob Agents Chemother 46 2002 3706 3711 (Pubitemid 35403240)
67. C. Jacqueline, D. Navas, E. Batard, A.F. Miegeville, V. Le Mabecque, and M.F. Kergueris In vitro and in vivo synergistic activities of linezolid combined with subinhibitory concentrations of imipenem against methicillin-resistant Staphylococcus aureus Antimicrob Agents Chemother 49 2005 45 51 (Pubitemid 40065771)
68. C. Jacqueline, J. Caillon, V. Le Mabecque, A.F. Miegeville, P.Y. Donnio, and D. Bugnon In vivo synergy of linezolid plus ertapenem combination in a methicillin-resistant Staphylococcus aureus rabbit endocarditis model. 45th Interscience Conference on Antimicrobial Agents and Chemotherapy (Icaac) 1999 American Society Of Microbiology Washington, DC
69. M.P. Stevens, and M.B. Edmond Endocarditis due to vancomycin-resistant enterococci: case report and review of the literature Clin Infect Dis 41 2005 1134 1142 (Pubitemid 41429476)
70. M.E. Falagas, K.G. Manta, F. Ntziora, and K.Z. Vardakas Linezolid for the treatment of patients with endocarditis: a systematic review of the published evidence J Antimicrob Chemother 58 2006 273 280 (Pubitemid 44313381)
71. P. Mancino, C. Ucciferri, K. Falasca, E. Pizzigallo, and J. Vecchiet Methicillin-resistant Staphylococcus epidermidis (MRSE) endocarditis treated with linezolid Scand J Infect Dis 40 2008 67 73
72. P. Muñoz, M. Rodríguez-Creixems, M. Moreno, M. Marín, V. Ramallo, and E. Bouza Linezolid therapy for infective endocarditis Clin Microbiol Infect 13 2007 211 215 (Pubitemid 46111620)
73. A. Colli, R. Campodonico, and T. Gherli Early switch from vancomycin to oral linezolid for treatment of Gram-positive heart valve endocarditis Ann Thorac Surg 84 2007 87 91 (Pubitemid 46921130)
74. J.R. Azanza, J. Barberan, J.A. García-Rodríguez, P. Llinares, J. Mensa, and J. Picazo Recommendations for the treatment of nosocomial infections caused by Gram-positive microorganisms Rev Esp Quimioter 17 2004 271 288 (Pubitemid 39577262)
75. C.F. Carpenter, and H.F. Chambers Daptomycin: another novel agent for treating infections due to drug-resistant Gram-positive pathogens Clin Infect Dis 38 2004 994 1000 (Pubitemid 38457208)
76. J.N. Steenbergen, J. Alder, G.M. Thorne, and F.P. Tally Daptomycin: a lipopeptide antibiotic for the treatment of serious Gram-positive infections J Antimicrob Chemother 55 2005 283 288 (Pubitemid 40425449)
77. G. Sakoulas, G.M. Eliopoulos, J. Alder, and C.T. Eliopoulos Efficacy of daptomycin in experimental endocarditis due to methicillin-resistant Staphylococcus aureus Antimicrob Agents Chemother 47 2003 1714 1718 (Pubitemid 36548559)
78. L. Cantoni, M.P. Glauser, and J. Bille Comparative efficacy of daptomycin, vancomycin, and cloxacillin for the treatment of Staphylococcus aureus endocarditis in rats and role of test conditions in this determination Antimicrob Agents Chemother 34 1990 2348 2353
79. J. Vouillamoz, P. Moreillon, M. Giddey, and J.M. Entenza Efficacy of daptomycin in the treatment of experimental endocarditis due to susceptible and multidrug-resistant enterococci J Antimicrob Chemother 58 2006 1208 1214 (Pubitemid 44884140)
80. K.H. Rand, and H.J. Houck Synergy of daptomycin with oxacillin and other beta-lactams against methicillin-resistant Staphylococcus aureus Antimicrob Agents Chemother 48 2004 2871 2875 (Pubitemid 38989149)
81. K.L. Laplante, and M.J. Rybak Impact of high-inoculum Staphylococcus aureus on the activities of nafcillin, vancomycin, linezolid, and daptomycin, alone and in combination with gentamicin, in an in vitro pharmacodynamic model Antimicrob Agents Chemother 48 2004 4665 4672 (Pubitemid 39577670)
82. F. Caron, M.D. Kitzis, L. Gutmann, A.C. Cremieux, B. Maziere, and J.M. Vallois Daptomycin or teicoplanin in combination with gentamicin for treatment of experimental endocarditis due to a highly glycopeptide-resistant isolate of Enterococcus faecium Antimicrob Agents Chemother 36 1992 2611 2616
83. M.C. Ramos, M.L. Grayson, G.M. Eliopoulos, and A.S. Bayer Comparison of daptomycin, vancomycin, and ampicillin-gentamicin for treatment of experimental endocarditis caused by penicillin-resistant enterococci Antimicrob Agents Chemother 36 1992 1864 1869
84. V.G. Fowler Jr, H.W. Boucher, G.R. Corey, E. Abrutyn, A.W. Karchmer, and M.E. Rupp Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus N Engl J Med 355 2006 653 665
85. M.E. Falagas, K.P. Giannopoulou, F. Ntziora, and K.Z. Vardakas Daptomycin for endocarditis and/or bacteraemia: a systematic review of the experimental and clinical evidence J Antimicrob Chemother 60 2007 7 19 (Pubitemid 47073272)
86. D.P. Levine, and K.C. Lamp Daptomycin in the treatment of patients with infective endocarditis: experience from a registry Am J Med 120 Suppl 1 2007 S28 S33
87. V.H. Chu, J.M. Miró, B. Hoen, C.H. Cabell, P.A. Pappas, and P. Jones Coagulase-negative staphylococcal prosthetic valve endocarditis - A contemporary update based on the international collaboration on endocarditis: prospective cohort study Heart 95 2009 570 576
88. G.M. Feuchtner, P. Stolzmann, W. Dichtl, T. Schertler, J. Bonatti, and H. Scheffel Multislice computed tomography in infective endocarditis: comparison with transesophageal echocardiography and intraoperative findings J Am Coll Cardiol 53 2009 436 444
89. X. Duval, B. Iung, I. Klein, E. Brochet, G. Thabut, and F. Arnoult Effect of early cerebral magnetic resonance imaging on clinical decisions in infective endocarditis: a prospective study Ann Intern Med 152 2010 497 504
90. E. Durante-Mangoni, S. Bradley, C. Selton-Suty, M.F. Tripodi, B. Barsic, and E. Bouza Current features of infective endocarditis in elderly patients: results of the International Collaboration On Endocarditis Prospective Cohort Study Arch Intern Med 168 2008 2095 2103
91. N. Benito, J.M. Miró, E. De Lazzari, C.H. Cabell, A. Del Río, and J. Altclas Health care-associated native valve endocarditis: importance of non-nosocomial acquisition Ann Intern Med 150 2009 586 594
92. M.A. Gerber, R.S. Baltimore, C.B. Eaton, M. Gewitz, A.H. Rowley, and S.T. Shulman Prevention of rheumatic fever and diagnosis and treatment of acute streptococcal pharyngitis: a scientific statement from the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee of the Council on Cardiovascular Disease in the Young, the Interdisciplinary Council on Functional Genomics and Translational Biology, and the Interdisciplinary Council on Quality of Care and Outcomes Research: endorsed by the American Academy of Pediatrics Circulation 119 2009 1541 1551
93. D. Yung, D. Kottachchi, B. Neupane, S. Haider, and M. Loeb Antimicrobials for right-sided endocarditis in intravenous drug users: a systematic review J Antimicrob Chemother 60 2007 921 928 (Pubitemid 47617736)
94. L.M. Baddour, A.E. Epstein, C.C. Erickson, B.P. Knight, M.E. Levison, and P.B. Lockhart Update on cardiovascular implantable electronic device infections and their management: a scientific statement from the American Heart Association Circulation 121 2010 458 477